Precigen (PGEN) Cash & Equivalents: 2012-2025
Historic Cash & Equivalents for Precigen (PGEN) over the last 14 years, with Sep 2025 value amounting to $14.3 million.
- Precigen's Cash & Equivalents fell 42.07% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 42.07%. This contributed to the annual value of $29.5 million for FY2024, which is 289.51% up from last year.
- According to the latest figures from Q3 2025, Precigen's Cash & Equivalents is $14.3 million, which was up 4.08% from $13.8 million recorded in Q2 2025.
- Precigen's Cash & Equivalents' 5-year high stood at $43.8 million during Q2 2022, with a 5-year trough of $4.9 million in Q4 2022.
- Its 3-year average for Cash & Equivalents is $14.5 million, with a median of $13.8 million in 2025.
- Its Cash & Equivalents has fluctuated over the past 5 years, first slumped by 86.66% in 2022, then spiked by 289.51% in 2024.
- Quarterly analysis of 5 years shows Precigen's Cash & Equivalents stood at $36.4 million in 2021, then tumbled by 86.66% to $4.9 million in 2022, then spiked by 55.99% to $7.6 million in 2023, then soared by 289.51% to $29.5 million in 2024, then crashed by 42.07% to $14.3 million in 2025.
- Its last three reported values are $14.3 million in Q3 2025, $13.8 million for Q2 2025, and $6.1 million during Q1 2025.